Back to mobile site

Haemonetics (HAE) Tops Q3 Views; Raises FY09 Outlook

October 27, 2008 8:56 AM EDT Send to a Friend
Haemonetics Corporation (NYSE: HAE) reports Q3 EPS of $0.58, ex-items, 6 cents better than the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login